DIS
62
2
NRG
50
-2
STI
31
19
GIS
29
3
NTAP
61
-3
UPS
50
9
DE
36
-2
MAT
38
-3
PM
58
2
PAYX
57
-2
SE
60
-5
CF
53
2
UA
57
4
CMG
69
-3
WFC
80
-2
FOX
57
-3
CTSH
65
-3
PWR
71
-3
RSG
77
4
ROK
67
5
DIS
62
2
NRG
50
-2
STI
31
19
GIS
29
3
NTAP
61
-3
UPS
50
9
DE
36
-2
MAT
38
-3
PM
58
2
PAYX
57
-2
SE
60
-5
CF
53
2
UA
57
4
CMG
69
-3
WFC
80
-2
FOX
57
-3
CTSH
65
-3
PWR
71
-3
RSG
77
4
ROK
67
5
Financhill
Back

Protagonist Therapeutics Vs. Dyne Therapeutics Industry Stock Comparison

Sell
29

PTGX
Protagonist Therapeutics

Last Price:
41.02
Seasonality Move:
12.96%
Sell
46

DYN
Dyne Therapeutics

Last Price:
30.40
Seasonality Move:
38.02%
Sell
29
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $41.04. The Score for PTGX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics a Buy, Sell or Hold?

  • The current Dyne Therapeutics [DYN] share price is $30.31. The Score for DYN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • DYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $41.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.

DYN Stock Price Chart

What is Dyne Therapeutics's stock price today?

  • The Dyne Therapeutics share price today is $30.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 31.27 Sell
Chaikin Money Flow: -545696 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.4 - 47.92) Sell
Bollinger Bands (100): (37.27 - 46.33) Sell

DYN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 47.11 Sell
Chaikin Money Flow: -1019710 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.92 - 33.44) Sell
Bollinger Bands (100): (31.39 - 42.57) Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.09 Sell
20-day SMA: 46.22 Sell
50-day SMA: 45.54 Sell
200-day SMA: 35.33 Buy
8-day EMA: 44.31 Sell
20-day EMA: 45.44 Sell
50-day EMA: 44.68 Sell
200-day EMA: 36.59 Buy

DYN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.77 Buy
20-day SMA: 30.55 Sell
50-day SMA: 32.55 Sell
200-day SMA: 32.11 Sell
8-day EMA: 30.26 Buy
20-day EMA: 30.69 Sell
50-day EMA: 32.85 Sell
200-day EMA: 30.82 Sell

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.95 per share.

Dyne Therapeutics Earnings Growth & DYN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.10 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dyne Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):